[Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)].
D001809:Blood Viscosity / Q000187:drug effects*; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002995:Clofibric Acid / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides; C009746:etofibrate; D002995:Clofibric Acid; D002784:Cholesterol; D002994:Clofibrate
Der Einfluss von Etofibrat auf die Plasmaviskosität bei Hyperlipoproteinämien.